https://orcid.org/0000-0003-1168-4041
References
- McDonald D, Ackermann G, Khailova L, et al. Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1(4):e00199-16.
- Limketkai BN, Hendler S, Ting PS, et al. Fecal microbiota transplantation for the critically ill patient. Nutr Clin Pract. 2019;34(1):73–79.
- Tirlapur N, Puthucheary ZA, Cooper JA, et al. Diarrhoea in the critically ill is common, associated with poor outcome, and rarely due to clostridium difficile. Sci Rep. 2016;6(1):24691–24691.
- Sertaridou E, Papaioannou V, Kolios G, et al. Gut failure in critical care: old school versus new school. Ann Gastroenterol. 2015;28(3):309–322.
- Lobionda S, Sittipo P, Kwon HY, et al. The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms. 2019;7(8):271.
- Gatt M, Reddy BS, MacFie J. Bacterial translocation in the critically ill - evidence and methods of prevention. Aliment Pharmacol Ther. 2007;25(7):741–757.
- Stelios F, Assimakopoulos SF, Triantos SF, et al. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751–760.
- Larsson A, Tydén J, Johansson J, et al. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scand J Clin Lab Invest. 2020;80(2):156–161.
- Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50–54.
- Mari A, Baker FA, Mahamid M, et al. Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician. Ann Gastroenterol. 2019;32(5):425–430.
- BÜHLMANN: product information [Internet]. Switzerland: BÜHLMANN Laboratories AG; c2022; [cited 2022 May 01]. Available from: https://www.buhlmannlabs.ch/products-solutions/clinical-chemistry/calprotectin/
- Juricic G, Brencic T, Tesija-Kuna A, et al. Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between method variability. Biochem. med. (Online). 2019;29(1):112–122.
- Malham M, Carlsen K, Riis L, et al. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis. Scand J Gastroenterol. 2019;54(10):1214–1219.